Lawmakers in the United States are urging President Joe Biden to increase scrutiny on Chinese biotech firms. The call comes as tensions between the two countries continue to escalate.
Members of Congress are pushing for more transparency and accountability from Chinese companies operating in the biotech sector. They argue that these firms may pose national security risks and could potentially steal intellectual property.
